Porcine VaccineMarket Overview 2025–2034: CAGR Trends, Long-Term Growth Paths, and Business Implications

May 27, 2025 by The Business Research Company

Discover trends, market shifts, and competitive outlooks for the porcine vaccine industry through 2025-2034 with The Business Research Company’s reliable data and in-depth research

#What Is the Current and Projected Market Size of the Porcine Vaccine Market Through 2034?#_x000D_

In the past few years, there has been a significant boost in the size of the porcine vaccine market. The market is projected to expand from $1.89 billion in 2024 to about $2.06 billion in 2025, representing a compound annual growth rate (CAGR) of 8.8%. The growth experienced in the historical period can be traced back to occurrences of disease outbreaks and the control measures that were implemented, an international rise in the consumption of pork, the intensification of pig farming practices, governmental strategies for disease prevention, and increase in awareness and educational programs._x000D_

_x000D_

Anticipated to experience significant expansion in the coming years, the porcine vaccine market is projected to increase to a value of $2.96 billion by 2029, with a CAGR of 9.5%. This augmentation during the forecasted period can be credited to the worldwide proliferation of pig farming, elevation in disease threats, rigid regulatory measures and adherence, advancements in vaccine technology, global trade, and risk mitigation of diseases. The forecasted period is expected to see key trends like the tailoring of vaccines to confront regional challenges, the incorporation of biotechnology in the production of vaccines, heightening apprehension over zoonotic ailments, the employment of genomic techniques in vaccine blueprint, and escalating investment in research and innovation._x000D_

_x000D_

#Download a free sample to assess the report’s scope and structure:#_x000D_

https://www.thebusinessresearchcompany.com/sample.aspx?id=9111&type=smp_x000D_

_x000D_

#What Are the Primary Drivers Supporting the Market Growth of the Porcine Vaccine Market?#_x000D_

The porcine vaccine market is expected to expand due to the continual rise in swine disease infection. Swine influenza, commonly known as swine flu, is a notable respiratory disorder in pigs majorly elicited by the type A influenza virus, often leading to serious influenza outbreaks in the pig population. To counteract this, porcine vaccines are introduced into pigs, causing the pig’s immune systems to respond and memorize the disease-causing agent by generating an immunogenic effect. These vaccines condition the swine’s immune system to counteract pathogens, preventing disease by showcasing a memory-based reaction upon future confrontations with the same pathogen. In September 2024, the UK government highlighted that an outbreak of African swine fever (ASF) holds the potential to severely impair the UK’s £8 billion pig industry, along with its £600 million annual exports of pork and pork by-products. The projected monetary implication of such an outbreak could be anywhere between £10 million and £100 million. Hence, the escalating prevalence of swine disease is a significant driving force for the porcine vaccine market._x000D_

_x000D_

#Which Primary Segments of the Porcine Vaccine Market Are Driving Growth and Industry Transformations?#_x000D_

The porcine vaccine market covered in this report is segmented –_x000D_

_x000D_

1) By Technology: Inactivated Vaccines, Live Attenuated Vaccines, Toxoid Vaccines, Recombinant Vaccines, Conjugate Vaccines, DNA Vaccines_x000D_

2) By Disease Indication: Diarrhea, Swine Influenza, Arthritis, Bordetella Rhinitis, Porcine Reproductive and Respiratory Virus (PRRSV), Porcine Circovirus Associated Disease (PCVAD), Other Disease Indications_x000D_

3) By End User: Veterinary Hospitals, Hog or Pig Production Farm_x000D_

_x000D_

Subsegments:_x000D_

1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines, Subunit Inactivated Vaccines_x000D_

2) By Live Attenuated Vaccines: Live Modified Vaccines, Live Virulent Vaccines_x000D_

3) By Toxoid Vaccines: Inactivated Toxins_x000D_

4) By Recombinant Vaccines: Recombinant Vector Vaccines, Subunit Recombinant Vaccines_x000D_

5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines_x000D_

6) By DNA Vaccines: Plasmid DNA Vaccines_x000D_

_x000D_

#Request customized data on this market:#_x000D_

https://www.thebusinessresearchcompany.com/customise?id=9111&type=smp_x000D_

_x000D_

#Which Regions Are Key Players in the Growth of the #What Are the Primary Drivers Supporting the Market Growth of the Porcine Vaccine Market?# Market?#_x000D_

North America is the largest region in the porcine vaccine market in 2024. The regions covered in the porcine vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa._x000D_

_x000D_

#What Are the Most Significant Market Trends in the Porcine Vaccine Market?#_x000D_

In the swiftly progressing animal health sector, prominent corporations in the porcine vaccine market are forming strategic alliances to bolster their research and development capacities and solidify their competitive advantage. The partnership leverages TVG’s knowledge in vaccine technology and Pirbright’s proficiency in African swine fever (ASF) research. The alliance’s objective is to refine the vaccine development procedure and formulate innovative methods that could significantly enhance pig health. For instance, in May 2024, The Vaccine Group (TVG), a UK-based firm, entered into a partnership with the UK-based Pirbright Institute to create an African swine fever (ASF) vaccine. The research is focused on developing vaccines aimed at preventing ASF using bovine herpesvirus 4 (BoHV-4) as a base. This method capitalizes on the newest advancements in ASF vaccine studies and pig immunology to create more effective vaccines. The initiative receives funding from the U.K.’s Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC)._x000D_

_x000D_

#View the full report here:#_x000D_

https://www.thebusinessresearchcompany.com/report/porcine-vaccine-global-market-report_x000D_

_x000D_

#What Parameters Are Used to Define the Porcine Vaccine Market?#_x000D_

Porcine vaccines are a medical and pharmaceutical treatment that improves the health of pigs by shielding them from different bacteria, viruses, and other infections. It is used to increase the efficacy of protecting pigs from harmful ailments while increasing the output of top-notch meat for human consumption._x000D_

_x000D_

#Purchase the full report and get a swift delivery:#_x000D_

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=9111_x000D_

_x000D_

#About The Business Research Company:#_x000D_

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game._x000D_

_x000D_

#Get in touch with us:#_x000D_

The Business Research Company: https://www.thebusinessresearchcompany.com/_x000D_

Americas +1 3156230293_x000D_

Asia +44 2071930708_x000D_

Europe +44 2071930708_x000D_

Email us at info@tbrc.info_x000D_

_x000D_

#Follow us on:#_x000D_

_x000D_

LinkedIn: https://in.linkedin.com/company/the-business-research-company_x000D_

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ_x000D_